Exchange Bulletin
Opsens Inc. (OPS) To Trade On Toronto Stock Exchange
February 27, 2017
| Issuer: | Opsens Inc. ("Opsens") |
| Security: | Common shares (the "Shares") |
| Symbol: | OPS |
| Number of securities issued and outstanding: | 83,254,780 Shares |
| Number of securities reserved for issuance: | 17,289,899 Shares |
| CUSIP: | 683823 10 8 |
| Trading currency: | CDN $ |
| Listing date: | March 1, 2017 (at the opening) |
| Posted for trading date: | March 1, 2017 (at the opening) |
| Listing category: | Industrial, Non-Exempt Issuer |
| Other market(s): | The Shares have been listed and trading on TSX Venture Exchange since October 17, 2006 under the symbol "OPS". The Shares will be delisted from TSX Venture Exchange on March 1, 2017, upon commencement of trading on Toronto Stock Exchange. |
| Temporary market maker: | Questrade Inc. |
| Security ownership registration: | Certificated issue |
| Investor relations: | Mr. Thierry Dumas (418) 781-0333 Email: thierry.dumas@opsens.com Mr. Louis Laflamme (418) 781-0333 Email: louis.laflamme@opsens.com |
| Incorporation: | Business Corporations Act (Québec) |
| Fiscal year end: | August 31 |
| Nature of business: | Opsens aims to become a key player in the guidewire Fractional Flow Reserve ("FFR") market with its OptoWire, a nitinol-based optical guidewire for FFR. The OptoWire provides intra-coronary blood pressure measurements with unique, patented optical pressure guidewire technologies. |
| Transfer agent and registrar: | CST Trust Company at its principal offices in Montréal and Toronto |
| Dividends: | None anticipated in the foreseeable future |
| Sponsorship: | Not applicable |
| Disclosure document: | Annual Information Form dated November 16, 2016 which is available at www.SEDAR.com. Capitalized terms not otherwise defined herein are as defined in the disclosure document. |
| TSX contact: | Julie K. Shin, Director, Listed Issuer Services, Toronto Stock Exchange |
